ArticleScientific reports2015

Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.

Renee N Cottle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.